SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+3.64%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$124M
AUM Growth
+$124M
(+39%)
Cap. Flow
+$34.7M
Cap. Flow
% of AUM
28.02%
Top 10 Holdings %
Top 10 Hldgs %
61.45%
Holding
51
New
18
Increased
5
Reduced
8
Closed
10
Top Buys
| 1 |
GSK
GSK
|
$10.6M |
| 2 |
RXDX
Ignyta, Inc.
RXDX
|
$7.89M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$6.78M |
| 4 |
AET
Aetna Inc
AET
|
$5.1M |
| 5 |
Amgen
AMGN
|
$4.35M |
Top Sells
| 1 |
Merck
MRK
|
$8.34M |
| 2 |
United Therapeutics
UTHR
|
$5.98M |
| 3 |
PFNX
Pfenex Inc.
PFNX
|
$5.96M |
| 4 |
UnitedHealth
UNH
|
$3.14M |
| 5 |
GTS
Triple-S Management Corporation
GTS
|
$2.24M |
Sector Composition
| 1 | Healthcare | 90.51% |
| 2 | Financials | 4.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $16.2M | 7.99% | 1,092,991 -30,650 | -3% | -$453K |
|
|
2
GSK
GSK
$79.9B
| $10.6M | 5.25% | +255,000 | New | +$10.6M |
|
|
RXDX
3
DELISTED
Ignyta, Inc.
RXDX
| $7.89M | 3.9% | +522,756 | New | +$7.89M |
|
|
AVDL
4
Avadel Pharmaceuticals
AVDL
$1.43B
| $6.78M | 3.35% | +320,000 | New | +$6.78M |
|
|
PFNX
5
DELISTED
Pfenex Inc.
PFNX
| $6.72M | 3.32% | 346,128 -307,265 | -47% | -$5.96M |
|
6
Johnson & Johnson
JNJ
$427B
| $6.26M | 3.09% | 64,177 +19,177 | +43% | +$1.87M |
|
|
PETX
7
DELISTED
Aratana Therapeutics, Inc.
PETX
| $6.12M | 3.02% | 404,738 +226,188 | +127% | +$3.42M |
|
8
Cardinal Health
CAH
$35.5B
| $5.29M | 2.62% | 63,278 +5,278 | +9% | +$441K |
|
9
Addus HomeCare
ADUS
$2.12B
| $5.18M | 2.56% | 186,055 -3,411 | -2% | -$95K |
|
|
DMK
10
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $5.13M | 2.54% | 1,222,260 +42,279 | +4% | +$178K |
|
|
AET
11
DELISTED
Aetna Inc
AET
| $5.1M | 2.52% | +40,000 | New | +$5.1M |
|
|
12
Amgen
AMGN
$155B
| $4.35M | 2.15% | +28,349 | New | +$4.35M |
|
|
HNGR
13
DELISTED
Hanger Inc.
HNGR
| $4.12M | 2.04% | +175,859 | New | +$4.12M |
|
14
Medtronic
MDT
$119B
| $4.11M | 2.03% | +55,400 | New | +$4.11M |
|
15
Ascendis Pharma
ASND
$11.8B
| $3.58M | 1.77% | +202,525 | New | +$3.58M |
|
16
Alnylam Pharmaceuticals
ALNY
$58.5B
| $3.24M | 1.6% | +27,000 | New | +$3.24M |
|
17
Stryker
SYK
$150B
| $3.18M | 1.57% | +33,300 | New | +$3.18M |
|
18
Cigna
CI
$80.3B
| $2.86M | 1.41% | +17,640 | New | +$2.86M |
|
19
Ironwood Pharmaceuticals
IRWD
$214M
| $2.86M | 1.41% | +237,000 | New | +$2.86M |
|
20
Avanos Medical
AVNS
$554M
| $2.43M | 1.2% | +60,000 | New | +$2.43M |
|
21
AbbVie
ABBV
$372B
| $2.24M | 1.11% | 33,291 -21,709 | -39% | -$1.46M |
|
|
ACHN
22
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $2.19M | 1.08% | +247,000 | New | +$2.19M |
|
|
ANTH
23
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $2.05M | 1.01% | +238,158 | New | +$2.05M |
|
|
FOMX
24
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.65M | 0.82% | +161,286 | New | +$1.65M |
|
25
SCYNEXIS
SCYX
$34.9M
| $1.43M | 0.7% | 162,175 +9,395 | +6% | +$82.6K |
|